EchoGo® Heart Failure vs Withings Scan Monitor
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is an AI platform designed for clinical diagnosis of HFpEF by analyzing echocardiograms within a healthcare system workflow. In contrast, Tool B, Withings Scan Monitor, focuses on personal and remote patient monitoring of various cardiac metrics, including AFib detection, through consumer-grade smart devices. While both leverage AI for cardiac health and are FDA-cleared, their distinct data inputs, deployment models, and primary use cases position them for different stages of patient care.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure (Tool A) is designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing routine echocardiograms. The Withings Scan Monitor (Tool B) offers FDA-cleared ECG for Atrial Fibrillation (AFib) detection, along with heart rate and irregular rhythm notifications.
EchoGou00ae Heart Failure (Tool A) is a cloud-based platform that offers seamless integration with existing IT stacks and workflows, delivering automated structured reports via DICOM to PACS within 20 minutes. The Withings Scan Monitor (Tool B) is device-based (smart scale, smartwatch) with cloud synchronization and a mobile application, primarily supporting remote patient monitoring and personal health management.
EchoGou00ae Heart Failure (Tool A) analyzes routine echocardiogram video clips to provide its insights. The Withings Scan Monitor (Tool B) utilizes data from its integrated devices, such as 6-lead ECG from the Body Scan and single-lead ECG from the ScanWatch, along with other vital health metrics.
EchoGou00ae Heart Failure (Tool A) is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis. The Withings Scan Monitor (Tool B) involves a device purchase (e.g., Body Scan ~$400-$500) with an optional monthly subscription for enhanced features and clinical services.
EchoGou00ae Heart Failure (Tool A) is FDA-cleared and clinically validated with 90% sensitivity and 86% specificity for HFpEF detection. The Withings Scan Monitor (Tool B) features FDA-cleared ECG for AFib detection, available as 6-lead on the Body Scan and single-lead on the ScanWatch.
EchoGou00ae Heart Failure (Tool A) delivers insights to support clinical decisions within 20 minutes of analyzing routine echocardiograms. For the Withings Scan Monitor (Tool B), data from the devices is automatically synchronized and available via its mobile application, providing near real-time access to measurements and AFib detection.
EchoGou00ae Heart Failure (Tool A) is suitable for patients undergoing routine echocardiograms where there is a need for rapid and accurate HFpEF detection. The Withings Scan Monitor (Tool B) is designed for patients who can benefit from remote monitoring of AFib, heart rate, and other vital health metrics through wearable and smart home devices, as well as for personal health management.